BIORELIANCE CORP
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: BIORELIANCE CORP, 10-Q, 2000-11-14
Next: ROCKDALE NATIONAL BANCSHARES INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 3RD
QUARTER 2000 FORM 10-Q UNAUDITED CONSOLIDATED BALANCE SHEETS AND UNAUDITED
CONSOLIDATED STATEMENTS OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-Q.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          11,255
<SECURITIES>                                     6,460
<RECEIVABLES>                                   20,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                40,261
<PP&E>                                          39,479
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  80,470
<CURRENT-LIABILITIES>                           15,464
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            81
<OTHER-SE>                                      53,106
<TOTAL-LIABILITY-AND-EQUITY>                    80,470
<SALES>                                         41,601
<TOTAL-REVENUES>                                41,601
<CGS>                                           27,475
<TOTAL-COSTS>                                   27,475
<OTHER-EXPENSES>                                12,534
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 664
<INCOME-PRETAX>                                  1,428
<INCOME-TAX>                                       602
<INCOME-CONTINUING>                                826
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       826
<EPS-BASIC>                                        .10
<EPS-DILUTED>                                      .10


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission